PlainPharmaWatch

CMS Open Payments · Program Year 2024

Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals LLC reported $3,108,260.33 in payments to 20,418 physicians and teaching hospitals across 20,499 transactions.

See the rankings → How this is sourced
$3.1M
Total payments
20,499
Transactions
20,418
Recipients
+$998.2K
General Payments vs PY2023

Amneal Pharmaceuticals LLC reported $3,108,260.33 in payments to 20,418 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #355 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $152.23 per recipient across 8 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Amneal Pharmaceuticals LLC pairs top-quartile payment volume with an unusually diversified payment pattern across a wide recipient base.

#355
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
8
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Amneal Pharmaceuticals LLC's CMS-reported General Payments increased by $998.2K (+105.6%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: AMNEAL PHARMACEUTICALS LLCPY2023: AMNEAL PHARMACEUTICALS LLCPY2024: Amneal Pharmaceuticals LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$945.0KPY2024$1.9M
PY2023
$945,031.31
PY2024
$1,943,241.59

How Amneal Pharmaceuticals LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Amneal Pharmaceuticals LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$3,108,260 Top 18% higher than 82% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Amneal Pharmaceuticals LLC

Averaging $151.63 per transaction and $152.23 per recipient, Amneal Pharmaceuticals LLC's Program Year 2024 total comes to $3,108,260.33 across 20,499 transactions and 20,418 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #355 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 8-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Honoraria" at $655.8K, accounting for 21.1% of the company's reported total and 212 transactions.

General Payment Breakdown by Type

Across 8 types of general payments, Amneal Pharmaceuticals LLC's largest category was "Honoraria" at $655.8K - 21.1% of the company's reported total.

How Amneal Pharmaceuticals LLC divides its payments

General-payment categories, ordered by reported total

1. Honoraria$655.8K2. Food and Beverage$468.0K3. Consulting Fee$316.5K4. Education$259.1K5. Travel and Lodging$105.7K6. Grant$67.1K7. Charitable Contribution$60.0K8. Compensation for Services…$11.1K
Payment Type Amount Transactions
Honoraria $655.8K 212
Food and Beverage $468.0K 19,581
Consulting Fee $316.5K 185
Education $259.1K 130
Travel and Lodging $105.7K 283
Grant $67.1K 5
Charitable Contribution $60.0K 19
Compensation for Services Other Than Consulting $11.1K 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $435,876.12 (22.4%) of $1,943,241.59 in this company's General Payments records across 6,761 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Amneal Pharmaceuticals LLC

The five named recipients with the highest reported General Payments from this company

Maria Ospina$112.6KStuart Isaacson$88.9KLaxman Bahroo$78.3KRamsey a Falconer$78.0KRobert Hauser$78.0K
  1. 1

    Maria Ospina

    $112,645.53 across 91 reported transactions

  2. 2

    Stuart Isaacson

    $88,922.64 across 41 reported transactions

  3. 3

    Laxman Bahroo

    $78,311.35 across 76 reported transactions

  4. 4

    Ramsey a Falconer

    $78,004.81 across 59 reported transactions

  5. 5

    Robert Hauser

    $77,991.79 across 39 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $151.63. Average per recipient: $152.23.

Total Amount

$3,108,260.33

Avg per Transaction

$151.63

Avg per Recipient

$152.23

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Amneal Pharmaceuticals LLC Share

0.0%

#355 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Amneal Pharmaceuticals LLC

Organogenesis Inc.

$3.1M 24,238 recipients

Whip Mix Corporation

$3.1M 19 recipients

NeuraMedica Inc.

$3.1M 0 recipients

Array Biopharma Inc

$3.1M 8,513 recipients

BioFire Diagnostics, LLC

$3.1M 11 recipients

Visby Medical, Inc.

$3.0M 30 recipients

Frequently Asked Questions

How much did Amneal Pharmaceuticals LLC pay to physicians and hospitals in 2024? ▾
Amneal Pharmaceuticals LLC made $3,108,260.33 in payments to physicians and hospitals in Program Year 2024, across 20,499 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Amneal Pharmaceuticals LLC? ▾
Amneal Pharmaceuticals LLC made payments to 20,418 physicians and teaching hospitals in 2024. The average payment per recipient was $152.23.
What types of payments did Amneal Pharmaceuticals LLC make? ▾
General payments from Amneal Pharmaceuticals LLC span 8 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Honoraria" at $655.8K, representing 21.1% of the company's reported total.
How does Amneal Pharmaceuticals LLC rank among pharmaceutical companies? ▾
Amneal Pharmaceuticals LLC ranks #355 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Amneal Pharmaceuticals LLC? ▾
In 2024, Amneal Pharmaceuticals LLC averaged $151.63 per transaction across 20,499 transactions to 20,418 recipients.
Where does the payment data for Amneal Pharmaceuticals LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Amneal Pharmaceuticals LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.